What Lab Work Is Done Before Starting Weight-Loss Medication?

Why does my doctor order labs before prescribing weight-loss medication?

Weight-loss medications work through different biological pathways, and several of those pathways interact with how the kidneys, liver, thyroid, and pancreas function. A pre-treatment lab panel serves three purposes: it identifies conditions that might make a specific medication unsafe or contraindicated; it establishes baseline values so that changes during treatment can be meaningfully compared; and it may reveal undiagnosed conditions — such as prediabetes or thyroid disease — that should shape the overall treatment plan 1Ref 1National Institute of Diabetes and Digestive and Kidney Diseases (2023).Prescription Medications to Treat Overweight and Obesity.Overview of the pre-prescribing evaluation process for weight-loss pharmacotherapy.

Labs are not a bureaucratic hurdle. They are a practical part of responsible prescribing.

What blood sugar tests will I need?

Blood sugar testing is nearly universal before weight-loss medication is started.

Fasting glucose measures your blood sugar after overnight fasting — a baseline snapshot. HbA1c (hemoglobin A1c) reflects average blood sugar over roughly the prior three months. Together, these establish whether you are in the normal range, the prediabetes range, or already meet criteria for type 2 diabetes.

This matters significantly for medication selection. GLP-1 receptor agonists (such as semaglutide and liraglutide) are often preferred when blood sugar is elevated because they improve insulin signaling alongside appetite. The American Diabetes Association recommends HbA1c as both a diagnostic tool and a monitoring metric for metabolic improvement over time 2Ref 2American Diabetes Association Professional Practice Committee (2024).Standards of Care in Diabetes—2024.HbA1c as a diagnostic and monitoring tool for diabetes and prediabetes in the context of weight and metabolic management.

What is a lipid panel, and why does it matter here?

A fasting lipid panel measures total cholesterol, LDL ("bad") cholesterol, HDL ("good") cholesterol, and triglycerides. Excess weight is commonly associated with elevated triglycerides and low HDL — both components of metabolic syndrome — and establishing this baseline matters for two reasons.

First, it documents your cardiovascular risk profile as part of the overall clinical picture. Second, some weight-loss medications, particularly GLP-1 agents, have documented effects on lipid levels; a clean baseline makes it easier to attribute future changes to the medication rather than to a pre-existing condition 3Ref 3Grundy SM, Stone NJ, Bailey AL, et al. (2019).2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol.Baseline lipid panel as part of cardiovascular risk assessment relevant to weight management planning.

Why do they check kidney and liver function?

A comprehensive metabolic panel (CMP) or basic metabolic panel (BMP) checks kidney function through creatinine and estimated glomerular filtration rate (eGFR), as well as liver enzymes (AST, ALT) and electrolytes.

Kidney function matters because some medications are processed through the kidneys and may need dose adjustments — or may be contraindicated — in people with reduced kidney function. Liver function matters because the liver metabolizes many drugs, and elevated liver enzymes may indicate fatty liver disease (common with metabolic syndrome) that warrants attention before starting medication. If you have a history of kidney or liver disease, this panel is especially important.

What does a thyroid test (TSH) tell the prescriber?

TSH (thyroid-stimulating hormone) testing checks whether the thyroid gland is functioning normally. An underactive thyroid (hypothyroidism) can cause weight gain, fatigue, and difficulty losing weight — symptoms that closely overlap with the reasons many people seek weight-loss support. If hypothyroidism is the undiagnosed driver, treating it first may itself improve metabolic function 4Ref 4Jonklaas J, Bianco AC, Bauer AJ, et al. (2014).Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement.Hypothyroidism as a treatable contributor to weight gain and metabolic difficulty, supporting TSH screening before starting weight-loss medication.

For GLP-1 medications specifically, the FDA prescribing information includes a counseling note about a theoretical thyroid tumor risk observed in animal studies. Clinicians use TSH testing in this context to review personal and family history of certain thyroid cancers before prescribing 5Ref 5Novo Nordisk (2024).WEGOVY (semaglutide) injection — FDA Prescribing Information.FDA prescribing information for semaglutide including thyroid tumor counseling, contraindications, and pre-treatment screening requirements.

What other tests might be ordered?

Depending on your history and the medication being considered, additional tests may follow:

• Complete blood count (CBC): a general health baseline
• Pregnancy test (urine or serum hCG): standard before most weight-loss medications, which are contraindicated in pregnancy
• Uric acid: checked if gout is a concern
• Hormonal panel: if features suggest PCOS or Cushing's syndrome as contributors to weight gain
• Blood pressure and pulse: measured in office rather than by blood draw, but equally important — especially before phentermine, which raises heart rate and blood pressure

If you have had a full lab panel within the past six to twelve months with no significant change in health status, some tests may not need repeating. Your clinician will review what's already in your chart 6Ref 6US Preventive Services Task Force (2021).Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement.Fasting glucose and HbA1c screening recommendations in adults with overweight or obesity.